Condensed Statement of Cash Flows (Unaudited)	3 Months Ended
	Mar. 31, 2017 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (165,090)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(61,666)
Changes in operating assets and liabilities:
Prepaid expenses	(86,790)
Accrued expenses	16,429
Net cash used in operating activities	(297,117)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(175,000,000)
Net cash used in investing activities	(175,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	171,940,000
Proceeds from sale of Placement Units	4,200,000
Proceed from issuance of common stock to Initial Stockholders	3,311
Repayment of promissory note - related parties	(231,846)
Payment of offering costs	(463,778)
Net cash provided by financing activities	175,447,687
Net Change in Cash and Cash Equivalents	150,570
Cash and Cash Equivalents - Beginning	82,614
Cash and Cash Equivalents - Ending	233,184
Non-Cash investing and financing activities:
Deferred underwriting fees charged to additional paid in capital	9,190,000
Deferred legal fees charged to additional paid in capital	25,000
Initial classification of common stock subject to possible redemption	161,314,270
Change in value of common stock subject to possible redemption	$ (166,946)